Desmopressin: Clinical Trials

52 trials of Desmopressin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 9 unknown, 8 terminated, 3 recruiting. 14 Phase 4, 10 Phase 3, 8 Not applicable, 8 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Unknown 4, Terminated 2, Withdrawn 1
Phase 310Completed 7, Terminated 2, Recruiting 1
Not applicable8Completed 5, Unknown 2, Recruiting 1
Phase 28Completed 4, Terminated 3, Recruiting 1
Phase 12Completed 2
Early Phase 11Unknown 1

Follow Desmopressin: new trials by email Literature Review of Desmopressin trials Research Report on Desmopressin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bedtime Device Restriction and Desmopressin in PMNE.
Desmopressin, Bedtime digital-device restriction - Primary Monosymptomatic Nocturnal Enuresis
Not applicableRecruitingAl-Azhar University1402026-08-202026-08-24
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Vitamin D, Desmopressin - Nocturnal Enuresis, Vitamin D Deficiency
Not applicableCompletedAin Shams University902024-12-152026-03-17
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
Desmopressin, Dexamethasone - Cushing Syndrome
Phase 2RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1402024-12-122026-08-31
Analysis of the Clinical Efficacy of Intravenous Application of Hemostatic Drugs in Improving the Clarity of Vision Under Endoscope, Perioperative Bleeding Volume and Anti-inflammatory Effect of Spinal Endoscopic Lumbar Fusion
Caroxime sodium sulfonate, Desmopressin, 0.9% Sodium Chloride Injection - Lumbar Spondylolisthesis, Arthrosis; Spine
Phase 4UnknownChengdu University of Traditional Chinese Medicine1262024-03-282024-03-15
Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis
Desmopressin - Nocturnal Enuresis
Not applicableUnknownAl-Azhar University502024-02-232024-04-23
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
Hypertonic 3% saline - Hyponatremia Symptomatic, Osmotic Demyelination Syndrome
Enrolling by invitationRochester General Hospital8002023-11-012026-08-26
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
Fluoxetine 20 MG, Desmopressin - Nocturnal Enuresis, Enuresis
Not applicableUnknownFayoum University Hospital602022-12-012023-12-29
Safety Outcomes Post Kidney Biopsy - Randomized Clinical Evaluation of Efficacy of Desmopressin
Desmopressin, intravenous infusion NaCl - Kidney Biopsy
Phase 3RecruitingMedical University of Bialystok4242022-09-012025-05-08
Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A
Desmopressin - Carrier of Hemophilia A, Desmopressin
CompletedGroupe Maladies hémorragiques de Bretagne3612022-01-012023-08-31
Desmopressin for Bedwetting in Children With SCD
Desmopressin - Nocturnal Enuresis, Anemia, Sickle Cell
Phase 4TerminatedMontefiore Medical Center82020-07-072024-05-07
Genetic Influence of Genetic Factors Influencing the Desmopressin's Efficacy in Mild/Moderate Hemophilia A
Desmopressin - Hemophilia A, Mild, Desmopressin
UnknownGroupe Maladies hémorragiques de Bretagne8002020-07-012022-11-28
Specified Drug Use-results Survey (Long-term Use) on MINIRINMELT® OD Tablet (Nocturia)
Desmopressin - Nocturia Due to Nocturnal Polyuria
CompletedFerring Pharmaceuticals10872020-05-192024-12-20
A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
BT200, Desmopressin, Placebo - Cerebrovascular Stroke, Large-Artery Atherosclerosis (Embolus/Thrombosis)
Phase 1CompletedBand Therapeutics1122019-10-072024-03-18
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer
Desmopressin - Castrate Resistance Prostate Cancer
Early Phase 1UnknownSunnybrook Health Sciences Centre102019-10-012019-10-02
Study on Chinese and Western Medicine in MNE Children
Desmopressin, Suoquan - Monosymptomatic Nocturnal Enuresis
Not applicableCompletedChildren's Hospital of Fudan University4002018-09-012021-03-11
To Evaluate the Renal Tubular Function Pre and Post Nephrectomy in Living Donors
Desmopressin - Kidney Damage
Phase 4WithdrawnUniversity of Kansas Medical Center2018-08-292019-05-20
The Effect of Selecting Treatment With Desmopressin or Alarm to Children With Enuresis Based on Home Recordings.
Desmopressin, Conditional alarm - Enuresis, Nocturnal
Phase 4CompletedUniversity of Aarhus3242017-10-012023-08-02
A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults
FE 201836, Desmopressin, Placebo oral solution - Nocturia
Phase 2CompletedFerring Pharmaceuticals3022017-07-272022-03-02
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
Desmopressin, Placebo - Nocturia
Phase 3CompletedFerring Pharmaceuticals1902016-09-012019-09-11
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Male Subjects
Desmopressin, Placebo - Nocturia
Phase 3CompletedFerring Pharmaceuticals3422016-09-012019-09-11

Showing 20 of 52. Sign in to see all of them.

Conditions studied

Nocturia (15)  ·  Nocturnal Enuresis (9)  ·  Diabetes Insipidus (3)  ·  Hemophilia A (3)  ·  Anemia, Sickle Cell (2)  ·  Endocrine System Diseases (2)  ·  Hemorrhage (2)  ·  Rare Diseases (2)  ·  Aortic Valve Stenosis (1)  ·  Blood Coagulation Disorders (1)  ·  Blood Loss, Surgical (1)  ·  Brain Edema (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Cushing Syndrome (1)

Sponsors

Ferring Pharmaceuticals (14)  ·  Al-Azhar University (2)  ·  Groupe Maladies hémorragiques de Bretagne (2)  ·  Laboratorio Elea Phoenix S.A. (2)  ·  Montefiore Medical Center (2)  ·  National Center for Research Resources (NCRR) (2)  ·  University Hospital, Ghent (2)  ·  University of Aarhus (2)  ·  Ain Shams University (1)  ·  Band Therapeutics (1)  ·  Chengdu University of Traditional Chinese Medicine (1)  ·  Children's Hospital of Fudan University (1)  ·  Chinese University of Hong Kong (1)  ·  Emory University (1)  ·  Fayoum University Hospital (1)

Countries

United States (13)  ·  Belgium (5)  ·  Canada (5)  ·  Japan (5)  ·  China (4)  ·  Egypt (4)  ·  Germany (3)  ·  Poland (3)  ·  Argentina (2)  ·  Denmark (2)  ·  France (2)  ·  South Korea (2)  ·  Austria (1)  ·  Brazil (1)  ·  Chile (1)

Top investigators

Gary L. Robertson (2)  ·  Karel Everaert, MD, PhD (2)  ·  Abul-fotouh Ahmed (1)  ·  Bahman Guyuron, MD (1)  ·  Dra. Ruth Weinberg (1)  ·  Eddie SY Chan (1)  ·  Enrique Roca, MD (1)  ·  Guri Greiff, MD (1)  ·  Harold P Drutz, MD (1)  ·  Hong Xu, MD.PhD. (1)

Results publications

PMID 31397969, PMID 40728007, PMID 23454402, PMID 23454404, PMID 25236993, PMID 26306290, PMID 27862898, PMID 31347012, PMID 32166534, PMID 32364251, PMID 34818873, PMID 34818875, PMID 38950376, PMID 42535456

NIH funding

2014 (1), 2016 (1)